LAWRENCE W VOESACK

Allopathic & Osteopathic Physicians|Family Medicine ODESSA, TX NPI 1932149663

General Payments — all program years on this page

$1,176.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $329.93 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $329.9317

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $150.1310
2019 $111.257
2020 $159.4210
2021 $130.707
2022 $141.687
2023 $153.848
2024 $329.9317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096897831 Novo Nordisk Inc $19.12 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097146684 Novo Nordisk Inc $16.92 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097607817 Novo Nordisk Inc $17.28 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097668939 Novo Nordisk Inc $15.89 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105245175 AstraZeneca Pharmaceuticals LP $20.01 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105397434 AstraZeneca Pharmaceuticals LP $14.28 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105465497 AstraZeneca Pharmaceuticals LP $15.02 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105514479 AstraZeneca Pharmaceuticals LP $19.21 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105746975 AstraZeneca Pharmaceuticals LP $18.57 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106290310 ABBVIE INC. $19.41 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114942492 Exact Sciences Corporation $22.28 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116659461 GlaxoSmithKline, LLC. $25.17 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000589 Otsuka America Pharmaceutical, Inc. $24.12 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135085698 Lilly USA, LLC $14.59 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135129554 Lilly USA, LLC $29.62 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137693312 Takeda Pharmaceuticals U.S.A., Inc. $18.88 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139347294 Astellas Pharma US Inc $19.56 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.